Table of Contents. Volume 4 Number 1 January S. S. Bhagyawant... 1

Size: px
Start display at page:

Download "Table of Contents. Volume 4 Number 1 January S. S. Bhagyawant... 1"

Transcription

1

2

3 Journal of Biosciences and Medicines, 2016, 4, Published Online January 2016 in SciRes. Table of Contents Volume 4 Number 1 January 2016 RAPD-SCAR Markers: An Interface Tool for Authentication of Traits S. S. Bhagyawant Evaluation of Life Quality and Dyspnea Intensity on Chronic Airway Diseases Patients in Pulmonary Rehabilitation Program K. J. Silva, G. D. Cordeiro, C. Rossinoli, M. L. Galhardo, M. M. Faganello.. 10 A Comparative Study on the Hemato-Biochemical and Immunological Effects of the Hexavalent FMD Vaccine Alone or in Combination with Trivalent FMD Vaccine in Cattle S. M. Shawky, N. S. Thabet, S. H. Orabi, M. A. Nayel.. 16 Cord Care Practices and Omphalitis among Neonates Aged 3-28 Days at Pumwani Maternity Hospital, Kenya L. Kinanu, E. Odhiambo, J. Mwaura, M. Habtu 27 Prevalence of Group A Rotavirus in Piglets in a Peri-Urban Setting of Arusha, Tanzania E. Gachanja, J. Buza, P. Petrucka.. 37 Endogenous Endothelin-1 Regulates Hypoxia-Induced Atrial Natriuretic Peptide Secretion by Activating the MAPK/ERK and PI3K/Akt Signaling Pathways in Isolated Beating Rabbit Atria C. C. Bian, D. Z. Ding, H. H. Jin, L. P. Liu, L. Hong, B. R. Cui, X. Cui 45 Evidence of Renal Damage in HIV-Infected Patients with High CD4 Counts Following the Use of Traditional Medicine N. Deebii, E. J. Nwankwo, O. S. Obi, M. T. Bekinbo 54 Chemical Fingerprint and Anti-Sickling Activity of Rosmarinic Acid and Methanolic Extracts from Three Species of Ocimum from DR Congo D. D. Tshilanda, P. K. Mutwale, D. V. N. Onyamboko, P. B. Babady, P. V. Tsalu, D. S. T. Tshibangu, N. K. Ngombe, M. Frederich, K. N. Ngbolua, P. T. Mpiana 59 Polymers in Drug Delivery A. Srivastava, T. Yadav, S. Sharma, A. Nayak, A. Kumari, N. Mishra 69

4 Journal of Biosciences and Medicines, 2016, 4, Published Online January 2016 in SciRes. In Vitro Antioxidant Properties of Phloretin An Important Phytocompound T. Nithiya, R. Udayakumar 85 Association between the Presence of Serumanti-Cardiolipin Antibodies and Infertility A.-R. Sh. Hasan, A. H. Hwaid, Z. H. Mahdy 95 A Short Report on Decompression Sickness Incidents in Andaman and Nicobar Islands S. Ahmed, A. Roy Effect of Hormonal Contraceptives on the Total Antioxidants Status of Women from Isolo, Lagos State, Nigeria E. N. Adejumo, I. O. Adediji, A. O. Akinmulero 107 Design, Synthesize and Bio-Evaluate 1,2-Dihydroisoquinolin-3(4H)-One Derivates as Acetylcholinesterase and β-secretase Dual Inhibitors in Treatment with Alzheimer s Disease Y. C. Deng, Y. R. Jiang, X. J. Zhao, J. L. Wang 112 The Incidence of Rotavirus and Adenovirus Infections among Children with Diarrhea in Sulaimani Province, Iraq D. O. Jaff, T. A. G. Aziz, N. R. Smith Correlation of Equol (7-Hydroxy-3-(4-Hydroxyphenyl)Chroman) in Woman Urine with the Symptoms of Menopause R. Y. Effriyanti, T. H. Madjid, H. H. Syam 132

5 Journal of Biosciences and Medicines (JBM) Journal Information SUBSCRIPTIONS The Journal of Biosciences and Medicines (Online at Scientific Research Publishing, is published monthly by Scientific Research Publishing, Inc., USA. Subscription rates: Print: $39 per issue. To subscribe, please contact Journals Subscriptions Department, SERVICES Advertisements Advertisement Sales Department, Reprints (minimum quantity 100 copies) Reprints Co-ordinator, Scientific Research Publishing, Inc., USA. COPYRIGHT COPYRIGHT AND REUSE RIGHTS FOR THE FRONT MATTER OF THE JOURNAL: Copyright 2016 by Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). COPYRIGHT FOR INDIVIDUAL PAPERS OF THE JOURNAL: Copyright 2016 by author(s) and Scientific Research Publishing Inc. REUSE RIGHTS FOR INDIVIDUAL PAPERS: Note: At SCIRP authors can choose between CC BY and CC BY-NC. Please consult each paper for its reuse rights. DISCLAIMER OF LIABILITY Statements and opinions expressed in the articles and communications are those of the individual contributors and not the statements and opinion of Scientific Research Publishing, Inc. We assume no responsibility or liability for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained herein. We expressly disclaim any implied warranties of merchantability or fitness for a particular purpose. If expert assistance is required, the services of a competent professional person should be sought. PRODUCTION INFORMATION For manuscripts that have been accepted for publication, please contact: jbm@scirp.org

6

7

Table of Contents. Volume 11 Number 4 August 2018

Table of Contents. Volume 11 Number 4 August 2018 9 771940 989007 04 Journal of Service Science and Management, 2018, 11, 343-495 http://www.scirp.org/journal/jssm ISSN Online: 1940-9907 ISSN Print: 1940-9893 Table of Contents Volume 11 Number 4 August

More information

Table of Contents. Volume 6 Number 3 July Analysis of Urban Innovation Efficiency in Guangdong-Hong Kong-Macao Greater Bay Area. S. Q.

Table of Contents. Volume 6 Number 3 July Analysis of Urban Innovation Efficiency in Guangdong-Hong Kong-Macao Greater Bay Area. S. Q. 9 772329 328004 03 Open Journal of Business and Management, 2018, 6, 539-795 http://www.scirp.org/journal/ojbm ISSN Online: 2329-3292 ISSN Print: 2329-3284 Table of Contents Volume 6 Number 3 July 2018

More information

Table of Contents. Volume 3 Number 10 October 2015

Table of Contents. Volume 3 Number 10 October 2015 Journal of Biosciences and Medicines, 2015, 3, 1-104 Published Online October 2015 in SciRes. http://www.scirp.org/journal/jbm Table of Contents Volume 3 Number 10 October 2015 Features of Otolithic Dysfunction

More information

Table of Contents. Volume 5 Number 11 November 2017

Table of Contents. Volume 5 Number 11 November 2017 9 772327 508002 11 Journal of Biosciences and Medicines, 2017, 5, 1-90 http://www.scirp.org/journal/jbm ISSN Online: 2327-509X ISSN Print: 2327-5081 Table of Contents Volume 5 Number 11 November 2017

More information

Table of Contents. Volume 4 Number 7 July K. Hiramoto, K. Orita, Y. Yamate, E. Kasahara... 1

Table of Contents. Volume 4 Number 7 July K. Hiramoto, K. Orita, Y. Yamate, E. Kasahara... 1 9 772327 508002 07 Journal of Biosciences and Medicines, 2016, 4, 1-114 Published Online July 2016 in SciRes. http://www.scirp.org/journal/jbm Table of Contents Volume 4 Number 7 July 2016 Role of the

More information

TABLE OF CONTENTS. Volume 1 Number 2 December 2010

TABLE OF CONTENTS. Volume 1 Number 2 December 2010 Low Carbon Economy, 2010, 1, 39-91 Published Online December 2010 in SciRes (http://www.scirp.org/journal/lce/) TABLE OF CONTENTS Volume 1 Number 2 December 2010 Analysis of Transient Dynamic Response

More information

Smart Grid and Renewable Energy

Smart Grid and Renewable Energy Smart Grid and Renewable Energy ISSN: 2151-481X Vol.1, No.3, November 2010 ISSN: 2151-481X www.scirp.org/journal/sgre 9 772151 481007 03 Smart Grid and Renewable Energy, 2010, 1, 109-171 Published Online

More information

Table of Contents. Volume 4 Number 8 October R. Baltaduonis, L. Rentschler

Table of Contents. Volume 4 Number 8 October R. Baltaduonis, L. Rentschler Theoretical Economics Letters, 2014, 4, 619-738 Published Online October 2014 in SciRes. http://www.scirp.org/journal/tel Table of Contents Volume 4 Number 8 October 2014 Common-Value Procurement Auctions

More information

Table of Contents. Volume 6 Number 4 August Unequal Exchange? Marx Solution to the Value Problem on the World Market. G. Sandleben.

Table of Contents. Volume 6 Number 4 August Unequal Exchange? Marx Solution to the Value Problem on the World Market. G. Sandleben. 9 772162 207009 04 Theoretical Economics Letters, 2016, 6, 621-836 Published Online August 2016 in SciRes. http://www.scirp.org/journal/tel Table of Contents Volume 6 Number 4 August 2016 Unequal Exchange?

More information

Table of Contents. Volume 4 Number 5 October 2014

Table of Contents. Volume 4 Number 5 October 2014 Open Journal of Forestry, 2014, 4, 431-580 Published Online October 2014 in SciRes. http://www.scirp.org/journal/ojf Table of Contents Volume 4 Number 5 October 2014 Analyzing the Relation between Greek

More information

Table of Contents. Volume 2 Number 4 March A. H. A. Ghafar, M. R. K. Ariffin L. Babenko, E. Maro G. H. Sun.. 18

Table of Contents. Volume 2 Number 4 March A. H. A. Ghafar, M. R. K. Ariffin L. Babenko, E. Maro G. H. Sun.. 18 Journal of Computer and Communications, 2014, 2, 1-231 Published Online March 2014 in SciRes. http://www.scirp.org/journal/jcc Table of Contents Volume 2 Number 4 March 2014 Timing Attack Analysis on AA

More information

Technology and Investment

Technology and Investment ISSN: 2150-4059 Volume 2, Number 2, May 2011 Scientific Research Technology and Investment ISSN: 2150-4059 www.scirp.org/journal/ti 9 7 7 2 1 5 0 4 0 5 0 0 4 0 2 Technology and Investment, 2011, 2, 65-153

More information

J. Water Resource and Protection, 2010, 2, Published Online October 2010 in SciRes ( TABLE OF CONTENTS

J. Water Resource and Protection, 2010, 2, Published Online October 2010 in SciRes (  TABLE OF CONTENTS J. Water Resource and Protection, 2010, 2, 849-922 Published Online October 2010 in SciRes (http://www.scirp.org/journal/jwarp/) TABLE OF CONTENTS Volume 2 Number 10 October 2010 Assessment of Groundwater

More information

Agricultural Sciences

Agricultural Sciences ISSN: 2156-8553 Vol.1, No.3, November 2010 Agricultural Sciences General overview of the Carica cubensis shrub (a) and detail of racine male flower, female or hermaphrodite flower and globose fruit in

More information

TABLE OF CONTENTS. Volume 1 Number 3 August Construction of Periodic Solutions of One Class Nonautonomous Systems of Differential Equations

TABLE OF CONTENTS. Volume 1 Number 3 August Construction of Periodic Solutions of One Class Nonautonomous Systems of Differential Equations Journal of Applied Mathematics and Physics, 2013, 1, 1-66 Published Online August 2013 in SciRes (http://www.scirp.org/journal/jamp/) TABLE OF CONTENTS Volume 1 Number 3 August 2013 Construction of Periodic

More information

TABLE OF CONTENTS. Volume 1 Number 2 November 2010

TABLE OF CONTENTS. Volume 1 Number 2 November 2010 Int. J. Clinical Medicine, 2010, 1, 37-86 Published Online November 2010 in SciRes (http://www.scirp.org/journal/ijcm/) TABLE OF CONTENTS Volume 1 Number 2 November 2010 Hyponatremia is Associated with

More information

TABLE OF CONTENTS. Volume 3, Number 11, November 2010

TABLE OF CONTENTS. Volume 3, Number 11, November 2010 Vol.3, No.11, 1041-1116 (2010) JBiSE TABLE OF CONTENTS Volume 3, Number 11, November 2010 Chondrogenic differentiation of stem cells in human umbilical cord stroma with PGA and PLLA scaffolds L. Zhao,

More information

TABLE OF CONTENTS. Volume 3 Number 1 January 2011

TABLE OF CONTENTS. Volume 3 Number 1 January 2011 Engineering, 2011, 3, 1-96 Published Online January 2011 in SciRes (http://www.scirp.org/journal/eng/) TABLE OF CONTENTS Volume 3 Number 1 January 2011 Reference Coordinate System of Nonlinear Beam Element

More information

TABLE OF CONTENTS. Volume 1 Number 2 December S. H. Wani, G. S. Sanghera, N. B. Singh 55

TABLE OF CONTENTS. Volume 1 Number 2 December S. H. Wani, G. S. Sanghera, N. B. Singh 55 American Journal of Plant Sciences, 2010, 1, 55-146 Published Online December 2010 in SciRes (http://www.scirp.org/journal/ajps/) TABLE OF CONTENTS Volume 1 Number 2 December 2010 Biotechnology and Plant

More information

Table of Contents. Volume 4 Number 16 December Identification of a Morphogenic Intermediate of the Bacteriophage Mu Baseplate

Table of Contents. Volume 4 Number 16 December Identification of a Morphogenic Intermediate of the Bacteriophage Mu Baseplate Advances in Microbiology, 2014, 4, 1155-1284 Published Online December 2014 in SciRes. http://www.scirp.org/journal/aim Table of Contents Volume 4 Number 16 December 2014 Identification of a Morphogenic

More information

Table of Contents. Volume 8 Number 1 January Complete Achilles Tenotomy: A New Improved Experimental Surgical Technique in Rats

Table of Contents. Volume 8 Number 1 January Complete Achilles Tenotomy: A New Improved Experimental Surgical Technique in Rats 9 772161 759004 01 Open Journal of Animal Sciences, 2018, 8, 1-117 http://www.scirp.org/journal/ojas ISSN Online: 2161-7627 ISSN Print: 2161-7597 Table of Contents Volume 8 Number 1 January 2018 Complete

More information

Table of Contents. Volume 6 Number 3 May Y. Dah-Traoré, L. Zerbo, M. Seynou, R. Ouedraogo 257

Table of Contents. Volume 6 Number 3 May Y. Dah-Traoré, L. Zerbo, M. Seynou, R. Ouedraogo 257 9 772327 407008 03 Journal of Minerals and Materials Characterization and Engineering, 2018, 6, 257-463 http://www.scirp.org/journal/jmmce ISSN Online: 2327-4085 ISSN Print: 2327-4077 Table of Contents

More information

TABLE OF CONTENTS. Volume 3 Number 1 March 2013

TABLE OF CONTENTS. Volume 3 Number 1 March 2013 Journal of Cosmetics, Dermatological Sciences and Applications, 2013, 3, 99-134 Published Online March 2013 in SciRes (http://www.scirp.org/journal/jcdsa/) TABLE OF CONTENTS Volume 3 Number 1 March 2013

More information

TABLE OF CONTENTS. Volume 3 Number 2 June Numerical Study on Optical Solitons Transmission System with 40 Gbit/s in the Photonic Crystal Fiber

TABLE OF CONTENTS. Volume 3 Number 2 June Numerical Study on Optical Solitons Transmission System with 40 Gbit/s in the Photonic Crystal Fiber Optics and Photonics Journal, 2013, 3, 141-224 Published Online June 2013 in SciRes (http://www.scirp.org/journal/opj/) TABLE OF CONTENTS Volume 3 Number 2 June 2013 Numerical Study on Optical Solitons

More information

TABLE OF CONTENTS. Volume 2, Number 12, December 2010

TABLE OF CONTENTS. Volume 2, Number 12, December 2010 Vol.2, No.12, 1327-1431 (2010) NS TABLE OF CONTENTS Volume 2, Number 12, December 2010 EARTH SCIENCE Well test analysis on pressure of viscoelastic polymer solution with variable rheological parameters

More information

TABLE OF CONTENTS. Volume 3 Number 3 July 2013

TABLE OF CONTENTS. Volume 3 Number 3 July 2013 Advances in Microbiology, 2013, 3, 227-308 Published Online July 2013 in SciRes (http://www.scirp.org/journal/aim/) TABLE OF CONTENTS Volume 3 Number 3 July 2013 Effect of Glucose Concentrations on the

More information

TABLE OF CONTENTS. Volume 1, Number 5, December 2010

TABLE OF CONTENTS. Volume 1, Number 5, December 2010 Vol.1, No.5, 367-452 (2010) ABB TABLE OF CONTENTS Volume 1, Number 5, December 2010 Quantitative determination of residual 2-(2-chloroethoxy) ethanol (CEE) in quetiapine fumarate by gas chromatogaraphy

More information

Table of Contents. Volume 8 Number 3 February V. J. Sebastian, R. Gupta J.-H. Chen, T. Van Trang Do

Table of Contents. Volume 8 Number 3 February V. J. Sebastian, R. Gupta J.-H. Chen, T. Van Trang Do 9 772162 207009 03 Theoretical Economics Letters, 2018, 8, 183-673 http://www.scirp.org/journal/tel ISSN Online: 2162-2086 ISSN Print: 2162-2078 Table of Contents Volume 8 Number 3 February 2018 Retail

More information

TABLE OF CONTENTS. Volume 5 Number 1 January 2013

TABLE OF CONTENTS. Volume 5 Number 1 January 2013 Energy and Power Engineering, 2013, 5, 1-128 Published Online January 2013 in SciRes (http://www.scirp.org/journal/epe/) TABLE OF CONTENTS Volume 5 Number 1 January 2013 Investigation and Mitigation of

More information

TABLE OF CONTENTS. Volume 4 Number 8A1 August S. M. Henninger. 1

TABLE OF CONTENTS. Volume 4 Number 8A1 August S. M. Henninger. 1 Journal of Environmental Protection, 2013, 4, 1-167 Published Online August 2013 in SciRes (http://www.scirp.org/journal/jep/) TABLE OF CONTENTS Volume 4 Number 8A1 August 2013 When Air Quality Becomes

More information

Vol.5, No.2A, (2013) TABLE OF CONTENTS. Volume 5, Number 2A, February A. E. Maxwell, M. P. Strager 229

Vol.5, No.2A, (2013) TABLE OF CONTENTS. Volume 5, Number 2A, February A. E. Maxwell, M. P. Strager 229 Vol.5, No.2A, 229-319 (2013) NS TABLE OF CONTENTS Volume 5, Number 2A, February 2013 Assessing landform alterations induced by mountaintop mining A. E. Maxwell, M. P. Strager 229 Differences in arsenic,

More information

TABLE OF CONTENTS. Volume 3 Number 4 December 2013

TABLE OF CONTENTS. Volume 3 Number 4 December 2013 Open Journal of Radiology, 2013, 3, 165-237 Published Online December 2013 in SciRes (http://www.scirp.org/journal/ojrad/) TABLE OF CONTENTS Volume 3 Number 4 December 2013 Splenic Arteriogastric Fistula

More information

TABLE OF CONTENTS. Volume 3 Number 4A November Aptamers A Promising Approach for Sensing of Biothreats Using Different Bioinformatics Tools

TABLE OF CONTENTS. Volume 3 Number 4A November Aptamers A Promising Approach for Sensing of Biothreats Using Different Bioinformatics Tools Soft Nanoscience Letters, 2013, 3, 1-50 Published Online November 2013 in SciRes (http://www.scirp.org/journal/snl/) TABLE OF CONTENTS Volume 3 Number 4A November 2013 Aptamers A Promising Approach for

More information

Vol.6, No.1, (2014) TABLE OF CONTENTS. Volume 6, Number 1, January 2014

Vol.6, No.1, (2014) TABLE OF CONTENTS. Volume 6, Number 1, January 2014 Vol.6, No.1, 1-140 (2014) Health TABLE OF CONTENTS Volume 6, Number 1, January 2014 Why don t the Dutch use quality information in their hospital choice? Results from a survey among 479 patients from a

More information

TABLE OF CONTENTS. Volume 2, Number 12, December Filaggrin mutations are associated with ichthyosis vulgaris in the Southern Chinese population

TABLE OF CONTENTS. Volume 2, Number 12, December Filaggrin mutations are associated with ichthyosis vulgaris in the Southern Chinese population Vol.2, No.12, 1345-1465 (2010) Health TABLE OF CONTENTS Volume 2, Number 12, December 2010 Filaggrin mutations are associated with ichthyosis vulgaris in the Southern Chinese population C.X. Li, Q. Luo,

More information

Agricultural Sciences

Agricultural Sciences ISSN: 2156-8553 Volume 7, Number 12, December 2016 Scientific Research Publishing Agricultural Sciences ISSN: 2156-8553 9 772156 855001 1 2 Journal Editorial Board ISSN Print: 2156-8553 ISSN Online: 2156-8561

More information

IQ4I Research & Consultancy Pvt. Ltd. Chronic Kidney Disease Pipeline Analysis

IQ4I Research & Consultancy Pvt. Ltd. Chronic Kidney Disease Pipeline Analysis IQ4I Research & Consultancy Pvt. Ltd. Chronic Kidney Disease Pipeline Analysis CONTENTS REPORT DESCRIPTION INTRODUCTION Causes & Symptoms Diagnosis Classification Epidemiology HOT TARGETS, MECHANISMS &

More information

TABLE OF CONTENTS. Volume 2, Number 3, August 2011

TABLE OF CONTENTS. Volume 2, Number 3, August 2011 9 772153 036007 03 Vol.2, No.3, 185-372 (2011) JBPC TABLE OF CONTENTS Volume 2, Number 3, August 2011 Thermodynamic solvation of a series of homologous α-amino acids in non-aqueous mixture of ethylene-glycol

More information

Public Private Partnerships for Sustainability

Public Private Partnerships for Sustainability Public Private Partnerships for Sustainability Autumn Ehnow London, UK January 12, 2012 Health for each woman, access for all women. Our Business Model requires partnership Partnerships for: 501c3 nonprofit

More information

ARCUSBIOSCIENCES,INC.

ARCUSBIOSCIENCES,INC. UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION WASHINGTON,DC20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d) ofthesecuritiesexchangeactof1934 DateofReport(Dateofearliesteventreported):May9,2018 ARCUSBIOSCIENCES,INC.

More information

First Place Essay. Katie P.

First Place Essay. Katie P. First Place Essay Katie P. Eighth Grade West Reading, PA 19611 Bioscience research is seeking information by exploring life's processes and diseases. It has helped many scientists understand how the body

More information

Supplementary Material. TRIB3 inhibits proliferation and promotes osteogenesis in hbmscs by regulating the. ERK1/2 signaling pathway

Supplementary Material. TRIB3 inhibits proliferation and promotes osteogenesis in hbmscs by regulating the. ERK1/2 signaling pathway Supplementary Material TRIB3 inhibits proliferation and promotes osteogenesis in hbmscs by regulating the ERK1/2 signaling pathway Cui Zhang 1, Fan-Fan Hong 1, Cui-Cui Wang 1, Liang Li 1, Jian-Ling Chen

More information

Synagis (Palivizumab) Drug Prior Authorization Protocol

Synagis (Palivizumab) Drug Prior Authorization Protocol Line of Business: Medi-Cal Effective Date: August 16, 2017 Revision Date: August 16, 2017 Synagis (Palivizumab) Drug Prior Authorization Protocol This policy has been developed through review of medical

More information

CAPACITY BUILDING WORKSHOP SUSTAINABILITY IN THE SUPPLY CHAIN

CAPACITY BUILDING WORKSHOP SUSTAINABILITY IN THE SUPPLY CHAIN CAPACITY BUILDING WORKSHOP SUSTAINABILITY IN THE SUPPLY CHAIN 90% of natural capital impact associated with consumer sector is embedded in supply chains Only 25% of the companies engage their suppliers

More information

CommitteeName_txt. Abuse Advisory Committee. Ad Hoc Committee on In Vitro Screening Devices. Advisory Committee of Immunization Practices (ACIP)

CommitteeName_txt. Abuse Advisory Committee. Ad Hoc Committee on In Vitro Screening Devices. Advisory Committee of Immunization Practices (ACIP) Abuse Advisory Committee Ad Hoc Committee on In Vitro Screening Devices Advisory Committee of Immunization Practices (ACIP) Advisory Committee on Special Studies Relating to the Possible Long-Term Health

More information

DATA FROM TRANSITION PROTOCOL MATERIALS TESTING AS OF JUNE 2013 DEMONSTRATES EVIDENCE OF FUNCTIONAL EQUIVALENCE.

DATA FROM TRANSITION PROTOCOL MATERIALS TESTING AS OF JUNE 2013 DEMONSTRATES EVIDENCE OF FUNCTIONAL EQUIVALENCE. DATA FROM TRANSITION PROTOCOL MATERIALS TESTING AS OF JUNE 13 DEMONSTRATES EVIDENCE OF FUNCTIONAL EQUIVALENCE. 73B Transition Protocol Materials Basis Weight Delamination * 2. 2. 2.1 2. 2.2 2. 2.3 oz/yd

More information

Ixef. PARA Single-Use Instrument (SUI) Life Cycle Analysis (LCA)

Ixef. PARA Single-Use Instrument (SUI) Life Cycle Analysis (LCA) Ixef PARA Single-Use Instrument (SUI) Life Cycle Analysis (LCA) The Carbon Footprint of Plastic Single Use Devices Does it measure up? 2 Ixef PARA Single-Use Instrument (SUI) Life Cycle Analysis (LCA)

More information

trial. Key trial data points:

trial. Key trial data points: February 23, 2015 ADMA Biologics Announces Positive Data on Primary and Secondary Endpoints from its Pivotal Phase III Clinical Trial for RI-002 at the AAAAI Medical Conference RAMSEY, N.J., Feb. 23, 2015

More information

EXPERT COLLECTION. Explore our leading medical review series

EXPERT COLLECTION. Explore our leading medical review series EXPERT COLLECTION Explore our leading medical review series Introducing the EXPERT COLLECTION The Taylor & Francis Expert Collection is the world s largest series of review journals in research, development,

More information

Abcam Plc. JP Morgan Healthcare Conference January 2017

Abcam Plc. JP Morgan Healthcare Conference January 2017 Abcam Plc JP Morgan Healthcare Conference January 2017 2 Disclaimer Important information The information provided in this presentation is for the sole use of those attending the presentation; it shall

More information

Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights New York, NY November 13, 2018 Mustang Bio, Inc. ( Mustang ) (NASDAQ: MBIO), a company focused on the development

More information

in Combating Malaria Manos Perros Pfizer Global Research & Development Musée de la Croix-Rouge, Geneva November 12, 2009

in Combating Malaria Manos Perros Pfizer Global Research & Development Musée de la Croix-Rouge, Geneva November 12, 2009 Role of the Private Sector in Combating Malaria Manos Perros Pfizer Global Research & Development Musée de la Croix-Rouge, Geneva November 12, 2009 Drug Development and the Evolving R&D Ecosystem Research

More information

What's New New Features in Primavera Analytics 18

What's New New Features in Primavera Analytics 18 What's New New Features in Primavera Analytics 18 Features introduced in 18.7 Support for Unifier Line Item Tabs for analyzing business processes. In the Business Process subject area, a Line Tab field

More information

ASBM Biosimilars. Canada Prescribers and Biosimilars October, Kevin Olson, CEO Industry Standard Research

ASBM Biosimilars. Canada Prescribers and Biosimilars October, Kevin Olson, CEO Industry Standard Research ASBM Biosimilars Canada Prescribers and Biosimilars October, 2017 Kevin Olson, CEO Industry Standard Research KevinO@ISRreports.com Table of contents Page 3 Methodology 5 Sample Characteristics 6 Executive

More information

Advancing Mitochondrial Medicine. Günther Metz, SVP Business Development

Advancing Mitochondrial Medicine. Günther Metz, SVP Business Development Advancing Mitochondrial Medicine Günther Metz, SVP Business Development Disclaimer 2 This presentation is not and under no circumstances to be construed as a solicitation, offer, or recommendation, to

More information

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution

More information

Introduction to Lassa fever

Introduction to Lassa fever Introduction to Lassa fever Managing infectious hazards Store food in containers with lids OpenWHO.org WHO2017 1 Learning objectives Describe signs, symptoms, and transmission of Lassa fever List 4 preventive

More information

Multiple Myeloma Training for Physicians 2018

Multiple Myeloma Training for Physicians 2018 Multiple Myeloma Training for Physicians 2018 Objective and Aim: The National University Cancer Institute, Singapore (NCIS) is the only public cancer centre in Singapore treating both paediatric and adult

More information

SciTechnol Mediakit. MatheMatics. Research and Reports on. Research Journal of Clinical Pediatrics

SciTechnol Mediakit. MatheMatics. Research and Reports on. Research Journal of Clinical Pediatrics SciTechnol Mediakit Research Journal of Clinical Pediatrics Research and Reports on MatheMatics www.scitechnol.com www.scitechnol.com Our Vision To publish, promote and disseminate the work of medical

More information

Human Atrial Natriuretic Peptide ELISA Kit

Human Atrial Natriuretic Peptide ELISA Kit Human Atrial Natriuretic Peptide Catalog Number: IRAAKT2501 ELISA Kit Lot No: SAMPLE INTENDED USE Atrial Natriuretic Peptide (ANP) was discovered in the early 1980s and described in publications in 1983/41,2.

More information

Highlight Product : QuickSwitch Custom Tetramer Kits. Featured Product : PCSK9 ELISA Kit & PCSK9-LDLR in vitro Binding Assay Kit

Highlight Product : QuickSwitch Custom Tetramer Kits. Featured Product : PCSK9 ELISA Kit & PCSK9-LDLR in vitro Binding Assay Kit vol.1 Sep. 2017 Highlight Product : QuickSwitch Custom Tetramer Kits Featured Product : PCSK9 ELISA Kit & PCSK9-LDLR in vitro Binding Assay Kit Attended The 8th International Symposium on Autophagy Hi,

More information

New Features in Primavera Contract Management 14.1

New Features in Primavera Contract Management 14.1 New Features in Primavera Contract Management 14.1 July 2014 COPYRIGHT & TRADEMARKS Copyright 2014 Oracle and/or its affiliates. All rights reserved. Oracle is a registered trademark of Oracle Corporation

More information

Step-by-Step Description of ELISA

Step-by-Step Description of ELISA Step-by-Step Description of ELISA The protocols in this kit rely on indirect antibody capture ELISA. The steps in this assay are: Step 1: Antigen is added to the wells of the microplate strip and incubated

More information

Oracle Hospitality RES 3700 Credit Card Interface

Oracle Hospitality RES 3700 Credit Card Interface Oracle Hospitality RES 3700 Credit Card Interface Release Notes Release 5.2 E81425-01 November 2016 Oracle Hospitality RES 3700 Credit Card Interface Release Notes, Release 5.2 E81425-01 Copyright 1998,

More information

From Bench To Clinic : a personal journey Career Research Advancement Focused Training

From Bench To Clinic : a personal journey Career Research Advancement Focused Training From Bench To Clinic : a personal journey Career Research Advancement Focused Training February 13, 2018 Irina Tcherepanova Ph.D. Vice President of Translational Medicine Argos Therapeutics Inc. FDA view

More information

Part 1 examination. Clinical Biochemistry: First paper. Tuesday 26 September Candidates must answer FOUR questions only

Part 1 examination. Clinical Biochemistry: First paper. Tuesday 26 September Candidates must answer FOUR questions only Tuesday 26 September 2017 Candidates must answer FOUR questions only Time allowed: three hours 1. Outline how pre-analytical factors can affect the results of clinical biochemistry tests and describe what

More information

CAUTION: U.S. Federal law restricts this device to sale by or on the order of a licensed physician.

CAUTION: U.S. Federal law restricts this device to sale by or on the order of a licensed physician. TM CAUTION: U.S. Federal law restricts this device to sale by or on the order of a licensed physician. TABLE OF CONTENTS Section Port Styles 4 Description 5 Indications 5 Contraindications 5-6 Information

More information

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication Guide each time you get more ribavirin tablets. There may

More information

Types of product/intervention

Types of product/intervention January 2017 This document contains information and guidance to assist users in selecting the appropriate type when reporting a medical product or intervention. This guidance is provided and governed by

More information

Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013

Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013 Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013 Indicative list Proposed topic /11 /11 /11 Identification and validation of innovative clinical endpoints for Osteoarthritis European genotype-phenotype

More information

Should IGRAs replace the TST?

Should IGRAs replace the TST? Should IGRAs replace the TST? Jim Rothel Melbourne, Australia Disclaimer: I am a consultant to Cellestis, a QIAGEN company Presentation Outline Comparative performance of QFT and the TST Is the TST / QFT

More information

Assessing quality-assured diagnoses made by TB laboratories

Assessing quality-assured diagnoses made by TB laboratories Assessing quality-assured diagnoses made by TB laboratories Quality-assured TB laboratory Objectives: at the end of the assessment reviewers should comment on the laboratory network and its structure;

More information

Chapter 10 Analytical Biotechnology and the Human Genome

Chapter 10 Analytical Biotechnology and the Human Genome Chapter 10 Analytical Biotechnology and the Human Genome Chapter Outline Enzyme tests and biosensors DNA-based tests DNA analysis technologies Human genome and genome-based analytical methods 1 Enzyme-based

More information

Unapproved Uses of Approved Drugs: The Physician, the Package Insert, and the Food and Drug Administration: Subject Review. Committee on Drugs

Unapproved Uses of Approved Drugs: The Physician, the Package Insert, and the Food and Drug Administration: Subject Review. Committee on Drugs Unapproved Uses of Approved Drugs: The Physician, the Package Insert, and the Food and Drug Administration: Subject Review ABSTRACT. Physicians who prescribe a new drug that has not been approved for a

More information

Veterinary & Animal Health

Veterinary & Animal Health Veterinary & Animal Health ANTIBODIES & ANTIGENS FOR COMMERCIAL IMMUNOASSAY DEVELOPMENT Veterinary health products including veterinary pharmaceuticals, biologicals and medicated feed additives (MFAs),

More information

Rates of infection after colonoscopy and osophagogastroduodenoscopy in ambulatory surgery centres in the USA

Rates of infection after colonoscopy and osophagogastroduodenoscopy in ambulatory surgery centres in the USA 1/5 This site uses cookies. More info Home / Online First Article Text Article menu Endoscopy Original article Rates of infection after colonoscopy and osophagogastroduodenoscopy in ambulatory surgery

More information

Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer s disease using its AMBAR treatment protocol

Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer s disease using its AMBAR treatment protocol Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer s disease using its AMBAR treatment protocol Grifols presents AMBAR (Alzheimer Management by Albumin Replacement)

More information

Case study: Specification of CD4+ T cell epitopes of human FVIII. Birgit Reipert Director Immunology TA Hemophilia/Hematology Baxter BioScience

Case study: Specification of CD4+ T cell epitopes of human FVIII. Birgit Reipert Director Immunology TA Hemophilia/Hematology Baxter BioScience Case study: Specification of CD4+ T cell epitopes of human FVIII Birgit Reipert Director Immunology TA Hemophilia/Hematology Baxter BioScience Mastering Immunogenicity, Boston MA, September 12-13 2011

More information

Synagis. Synagis (palivizumab) Description. Section: Prescription Drugs Effective Date: July 1, 2016

Synagis. Synagis (palivizumab) Description. Section: Prescription Drugs Effective Date: July 1, 2016 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.20.04 Section: Prescription Drugs Effective Date: July 1, 2016 Subject: Synagis Page: 1 of 5 Last Review

More information

Jan Willem van der Laan

Jan Willem van der Laan First-in-human studies: Recent experiences in Europe Jan Willem van der Laan Section Pharmacological-Toxicological and Biotechnology Assessment Medicines Evaluation Board, Utrecht First-in-human trials

More information

Thursday 26 May 2016 Afternoon Time allowed: 1 hour 30 minutes

Thursday 26 May 2016 Afternoon Time allowed: 1 hour 30 minutes Please write clearly in block capitals. Centre number Candidate number Surname Forename(s) Candidate signature AS BIOLOGY Paper 1 Thursday 26 May 2016 Afternoon Time allowed: 1 hour 30 minutes Materials

More information

Supplemental Material for: Delineating antibody recognition against Zika

Supplemental Material for: Delineating antibody recognition against Zika Supplemental Material for: Delineating antibody recognition against Zika virus during natural infection Authors: Lei Yu 1,8, Ruoke Wang 2,8, Fei Gao 2, Min Li 3, Jianying Liu 4, Jian Wang 1,Wenxin Hong

More information

Immunology 101: Implications for Medical Device Failure. Joshua B. Slee, PhD Assistant Professor of Biology

Immunology 101: Implications for Medical Device Failure. Joshua B. Slee, PhD Assistant Professor of Biology Immunology 101: Implications for Medical Device Failure Joshua B. Slee, PhD Assistant Professor of Biology Learning Goals Understand innate and adaptive immunity Explain how innate and adaptive immunity

More information

Drug Use Evaluation: Synagis (palivizumab) Summary of Findings:

Drug Use Evaluation: Synagis (palivizumab) Summary of Findings: Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-945-5220 Fax 503-947-1119 Drug Use Evaluation: Synagis (palivizumab) Summary

More information

Role of MedDRA in Healthcare. MedDRA trademark is owned by IFPMA on behalf of ICH

Role of MedDRA in Healthcare. MedDRA trademark is owned by IFPMA on behalf of ICH Role of MedDRA in Healthcare MedDRA trademark is owned by IFPMA on behalf of ICH MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration

More information

DATA FROM DEVELOPMENTAL MATERIAL TESTING AS OF SEPTEMBER 2012 DEMONSTRATES EVIDENCE OF FUNCTIONAL EQUIVALENCE.

DATA FROM DEVELOPMENTAL MATERIAL TESTING AS OF SEPTEMBER 2012 DEMONSTRATES EVIDENCE OF FUNCTIONAL EQUIVALENCE. DATA FROM DEVELOPMENTAL MATERIAL TESTING AS OF SEPTEMBER 212 DEMONSTRATES EVIDENCE OF FUNCTIONAL EQUIVALENCE. 173B Materials Basis Weight Delamination 2.5 2.1 2.15 2.2 oz/yd 2 2.25 2. 2.35.3.4.5.6 /in..7.8.9

More information

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,

More information

CA Cloud Service Delivery Platform

CA Cloud Service Delivery Platform CA Cloud Service Delivery Platform Overview Guide Version 01.0.00 This Documentation, which includes embedded help systems and electronically distributed materials, (hereinafter referred to as the Documentation

More information

Sage What's new

Sage What's new Sage 300 2017 What's new This is a publication of Sage Software, Inc. Copyright 2016. Sage Software, Inc. All rights reserved. Sage, the Sage logos, and the Sage product and service names mentioned herein

More information

GLOBAL DISPOSABLE MEDICAL DEVICES SENSORS MARKET

GLOBAL DISPOSABLE MEDICAL DEVICES SENSORS MARKET GLOBAL DISPOSABLE MEDICAL DEVICES SENSORS MARKET By Type [Biosensor, Image Sensor, Accelerometer] Monitoring [Smart Pill, Pulse Oximeter] Diagnostic [Capsule Endoscope, Blood Glucose Strip] Therapeutic

More information

Clinical Policy: Palivizumab (Synagis) Reference Number: ERX.SPA.124 Effective Date: Last Review Date: 08.17

Clinical Policy: Palivizumab (Synagis) Reference Number: ERX.SPA.124 Effective Date: Last Review Date: 08.17 Clinical Policy: (Synagis) Reference Number: ERX.SPA.124 Effective Date: 10.01.16 Last Review Date: 08.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

New Features in Primavera Contract Management 14.2

New Features in Primavera Contract Management 14.2 New Features in Primavera Contract Management 14.2 COPYRIGHT & TRADEMARKS Copyright 2015, Oracle and/or its affiliates. All rights reserved. Oracle is a registered trademark of Oracle Corporation and/or

More information

Fundamentals of Immunology

Fundamentals of Immunology Otto G. Bier Wilmar Dias da Silva Dietrich Gotze Ivan Mota Fundamentals of Immunology Completely Revised Second Edition With a Contribution by Reinhard Burger With 173 Figures Springer -Verlag Berlin Heidelberg

More information

New Features in Primavera Analytics 16.2

New Features in Primavera Analytics 16.2 New Features in Primavera Analytics 16.2 COPYRIGHT & TRADEMARKS Copyright 2016, Oracle and/or its affiliates. All rights reserved. Oracle is a registered trademark of Oracle Corporation and/or its affiliates.

More information

InnoZyme TACE Activity Kit Cat. No. CBA042

InnoZyme TACE Activity Kit Cat. No. CBA042 User Protocol CBA042 Rev. 26 January 2006 JSW Page 1 of 5 InnoZyme TACE Activity Kit Cat. No. CBA042 Note that this user protocol is not lot-specific and is representative of the current specifications

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Synagis) Reference Number: CP.PHAR.16 Effective Date: 08.01.09 Last Review Date: 05.18 Line of Business: Commercial, Medicaid, HIM-Medical Benefit Revision Log See Important Reminder

More information

ADVANCING SCIENTIFIC INNOVATION Together, the possibilities are endless.

ADVANCING SCIENTIFIC INNOVATION Together, the possibilities are endless. ADVANCING SCIENTIFIC INNOVATION Together, the possibilities are endless. COMMUNICATE INNOVATE EXPLORE COLLABORATE PARTNERSHIPS THAT BENEFIT YOU, US, AND ALL OF MANKIND Since Eli Lilly and Company was founded

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Synagis) Reference Number: CP.HNMC.159 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy

More information

Securing Intel s External Online Presence

Securing Intel s External Online Presence IT@Intel White Paper Intel IT IT Best Practices Information Security May 2011 Securing Intel s External Online Presence Executive Overview Overall, the Intel Secure External Presence program has effectively

More information

Read Me First: Unpacking Express5800/320Ma 3.2 GHz, 3.6 GHz, and Dual-Core Systems

Read Me First: Unpacking Express5800/320Ma 3.2 GHz, 3.6 GHz, and Dual-Core Systems Read Me First: Unpacking Express5800/320Ma 3.2 GHz, 3.6 GHz, and Dual-Core Systems NEC Solutions (America), Inc. NR579-02 Notice The information contained in this document is subject to change without

More information